Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks at record high but yields fall, dollar under pressure

Fri, 27th Nov 2020 20:02

* Highly anticipated vaccine facing more scrutiny

* Treasury yields fall, point to lingering COVID-19 worries

* Bitcoin extends Thursday's big losses

* USD index closes at 2-1/2 year low

* U.S. markets on shortened hours after Thanksgiving holiday

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh
(Updates to U.S. market close)

By Rodrigo Campos

NEW YORK, Nov 27 (Reuters) - Stocks rose across the globe on Friday to close
at a fresh high and remained on track for their strongest monthly performance on
record but the Nasdaq outperformed on Wall Street and Treasury yields fell,
indicating lingering concerns over rising coronavirus cases globally.

A global stock index touched a record high for the third session this week
while the dollar index, a measure of the greenback versus six peers, touched a
three-month low and closed at its lowest since April 2018.

On Wall Street, the main indexes rose and the Nasdaq Composite hit a record
high. The Nasdaq outperformance mirrors recent sessions when, despite rising
stocks, the focus was on the economic impact of the pandemic. The U.S. expects a
further surge in coronavirus infections following the Thanksgiving holiday.

The Dow Jones Industrial Average rose 37.9 points, or 0.13%, to
29,910.37, the S&P 500 gained 8.7 points, or 0.24%, to 3,638.35 and the
Nasdaq Composite added 111.44 points, or 0.92%, to 12,205.85.

European stocks rose after the European Central Bank reinforced expectations
of further stimulus next month and Sweden's Riksbank made a surprise increase to
its quantitative-easing program.

The pan-European STOXX 600 index rose 0.41% and MSCI's gauge of
stocks across the globe gained 0.39% to 623.75 after touching a
high of 624.29.

Emerging market stocks rose 0.12%, while Japan's Nikkei rose 0.40%.

Questions also lingered over trial data on AstraZeneca's COVID-19
"vaccine for the world," as several scientists sounded caution over the trial
results.

Australian shares ended down 0.5% with Treasury Wine Estates
down 11.25% as China imposed new tariffs on Australian wine, the latest
move in the countries' long-running trade row.

The European Union and Britain said substantial differences remained over a
Brexit trade deal, as the EU chief negotiator prepared to travel to London in a
last-ditch attempt to avoid a tumultuous finale to the five-year crisis.

Sterling, which has climbed over 3% against the dollar this month, was last
trading at $1.3299, down 0.42% on the day.

"Clearly, there are substantial and important differences still to be
bridged, but we're getting on with it," British Prime Minister Boris Johnson
told reporters.

The dollar index fell 0.269%, with the euro up 0.39% to
$1.196. The Japanese yen strengthened 0.24% versus the greenback at 104.03 per
dollar.

"Over the longer term, this is probably the right trend for the dollar. We
think the dollar has further room to the downside," said Bipan Rai, North
America head of foreign exchange strategy at CIBC Capital Markets.

The yield on benchmark Treasury notes fell as some investors
sought the safety of holding government debt over persistent concerns about the
surge in coronavirus cases and lockdowns in several U.S. states and around the
world.

The 10-year notes last rose 11/32 in price to yield 0.8422%, from 0.878%
late on Wednesday.

Oil prices, up for a fourth straight week, were mixed.

U.S. crude recently fell 0.42% to $45.52 per barrel and Brent
was at $48.27, up 0.98% on the day. Both rose over 7% this week.

Bitcoin fell 2.25% to $16,774.49 after tumbling 8.4% in the
previous session. The cryptocurrency brushed against its record high of $19,666
earlier this week and has rallied around 130% this year.

Spot gold dropped 1.3% to $1,787.40 an ounce. Silver fell
3.20% to $22.70.

(Reporting by Rodrigo Campos; additional reporting by Sinéad Carew in New York,
Marc Jones in London and Shivani Kumaresan in Bengaluru
Editing by Nick Zieminski
)

More News
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.